Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K153561
    Date Cleared
    2017-02-16

    (430 days)

    Product Code
    Regulation Number
    862.1345
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K110017

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The AG-607 blood glucose monitoring system is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip, palm, forearm, calf, or thigh. The AG-607 blood glucose monitoring system is intended to be used by a Single person and should not be shared.

    The AG-607 blood glucose monitoring system is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control. The AG-607 blood glucose monitoring system should not be used for the diagnosis of or screening for diabetes, nor for neonatal use. Alternative Site Testing (AST) should be done only during steady-state times (when glucose levels is not changing rapidly).

    The EGS-2003 test strips are for use with the AG-607 blood glucose meter to quantitatively measure glucose(sugar) in fresh capillary whole blood samples drawn from the fingertips, palm, forearm, calf or thigh.

    The AG-607Multi blood glucose monitoring system is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip, palm, forearm, calf, or thigh. The AG-607Multi blood glucose monitoring system is intended for testing outside the body(in vitro diagnostic use) and is intended for multiple-patient use in professional healthcare settings as and aid to monitor the effectiveness of diabetes control program. The system is only used with single-use auto-disabling lancing device.

    The AG-607Multi blood glucose monitoring system should not be used for the diagnosis of or screening for diabetes, nor for neonatal use. Alternative Site Testing (AST) should be done only during steady-state times (when glucose levels is not changing rapidly).

    The EGS-2003Multi test strips are for use with the AG-607Multi blood glucose meter to quantitatively measure glucose(sugar) in fresh capillary whole blood samples drawn from the fingertips, palm, forearm, upper arm, calf or thigh.

    Device Description

    The AG-607 and AG-607 Multi Glucose Monitoring System (BGMS) consist of blood glucose meter, single use test strips, sterile lancets, lancing device and the control solutions.

    They are based on an electrochemical biosensor technology (electrochemical) and the principle of capillary action. Capillary action at the end of the test strip draws the blood into the action chamber and the blood glucose result is displayed in 5 seconds. The control solution available is used to test the performance of the device. It uses the same technological characteristics for testing with its predicate device.

    AI/ML Overview

    The document describes the AG-607 and AG-607 Multi Blood Glucose Monitoring Systems. Here's a breakdown of the requested information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are based on ISO 15197 for in vitro diagnostic test systems for self-testing in managing diabetes mellitus. The document explicitly states that the device conforms to this standard. However, specific numerical performance criteria from ISO 15197 and the device's reported numerical performance against those criteria are not provided in detail in this document.

    The document mentions a "Measurement Range" for the device. While this is a performance characteristic, it's not presented as an acceptance criterion against which specific test results are directly compared in a table.

    Implied Performance (from device specifications):

    Feature/SpecificationAG-607 Blood Glucose Monitoring System
    Detection MethodAmperometry
    EnzymeGlucose dehydrogenase
    Sample SourceCapillary whole blood from AST and finger
    Hematocrit Range20-60%
    Operating Temperature Range$10\degree C~40\degree C (50\degree-104\degree F)$
    Test Time5 second
    Measurement Range20mg/dL-600mg/dL (1.1mmol/L~33.3mmol/L)
    Sample VolumeMinimum 0.7 micro liter

    2. Sample Size Used for the Test Set and Data Provenance

    The document states "Non-clinical test and the clinical test are done according to the above standard [ISO 15197]". However, actual sample sizes for the test set (both non-clinical and clinical) are not specified in this document. The data provenance (e.g., country of origin of the data, retrospective or prospective) is also not explicitly mentioned.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of those Experts

    This information is not provided in the document. For a blood glucose monitoring system, the ground truth is typically established against a laboratory reference method, not by human experts.

    4. Adjudication Method for the Test Set

    This information is not provided in the document. Since blood glucose measurements are quantitative and typically compared against a reference method, an adjudication method for conflicting expert opinions would not typically apply.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was Done, If so, What was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

    This is not applicable as the device is a blood glucose monitoring system, not an AI-assisted diagnostic tool that involves human readers interpreting cases.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done

    The device is a standalone blood glucose monitoring system. Its performance is evaluated independently of human interpretation of complex images or data. The document states "Non-clinical test and the clinical test are done according to the above standard [ISO 15197]", implying a standalone performance evaluation.

    7. The Type of Ground Truth Used

    While not explicitly stated, for blood glucose monitoring systems complying with ISO 15197, the ground truth is typically established using a laboratory reference method (e.g., a YSI analyzer) which is considered highly accurate for glucose concentration.

    8. The Sample Size for the Training Set

    This information is not provided in the document. Blood glucose measurement devices typically do not involve a "training set" in the machine learning sense. Instead, they are calibrated during manufacturing and their accuracy is verified through testing.

    9. How the Ground Truth for the Training Set Was Established

    This information is not provided in the document and is generally not applicable in the context of such devices. Calibration and verification processes ensure the device's accuracy against known glucose concentrations.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1